1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Dipeptidyl Peptidase
  4. DPP-2 Isoform

DPP-2

DPP-2, also called DPP7 or quiescent cell proline dipeptidase, is an intracellular serine protease isolated from CD26- Jurkat T cells after inhibitors of post-proline cleaving aminodipeptidases caused apoptosis in quiescent lymphocytes independent of CD26/DPPIV[1]. Mechanistically, DPP-2 cleaves N-terminal X-Pro dipeptides, and this cleavage can alter chemokines including RANTES, stroma-derived factor-1, and macrophage-derived chemokine[2]. DPP-2 supports cell-cycle quiescence because it is essential for maintaining lymphocytes and fibroblasts in G0, and its inhibition induces apoptosis through c-Myc and p53[3]. In chronic lymphocytic leukemia, DPP-2 inhibition-induced apoptosis identifies B-cell activation stage and predicts prognosis[4]. Compared with DPPIV/CD26, DPP-2 has similar substrate specificity but localizes to intracellular vesicles rather than the cell surface[2]. Compared with DPP-IV and DPP-VII, biochemical profiling defined distinct catalytic and inhibition properties among proline-specific dipeptidyl peptidases[5]. For experimental applications, a cell-permeable azabicyclo[3.3.0]octane-based DPP-2 inhibitor showed potency, selectivity, and quiescent lymphocyte death similar to less selective inhibitors[6].

DPP-2 Related Products (2):

Cat. No. Product Name Effect Purity
  • HY-15695
    Puromycin aminonucleoside
    Inhibitor 99.86%
    Puromycin aminonucleoside (NSC 3056) is the aminonucleoside portion of the antibiotic puromycin, and used in nephrosis animal models. Puromycin aminonucleoside induces apoptosis. Puromycin aminonucleoside is a reversible inhibitor of dipeptidyl peptidase II and cytosol alanyl aminopeptidase. Puromycin aminonucleoside induces secretion of cell migrasome.
  • HY-182374
    AX8819
    Inhibitor
    AX8819 is a selective dipeptidyl peptidase II (DPP II) inhibitor with an IC50 of 0.88 nM. AX8819 induces caspase-dependent apoptosis. AX8819 exhibits low non-specific toxicity toward proliferating T cells. AX8819 can be used for the research of B cell chronic lymphocytic leukemia.